Lymphoma and systemic sclerosis - An uncommon association or possible coincidence of two disorders with a fatal outcome [2]

Y. S. Haviv; A. Ben-Yehuda; A. Polliack; R. Safadi

doi:10.1111/j.1600-0609.1997.tb00975.x

Lymphoma and systemic sclerosis - An uncommon association or possible coincidence of two disorders with a fatal outcome [2]

Y. S. Haviv
, A. Ben-Yehuda
, A. Polliack
, R. Safadi

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	194-196
Number of pages	3
Journal	European Journal of Haematology
Volume	59
Issue number	3
DOIs	https://doi.org/10.1111/j.1600-0609.1997.tb00975.x
State	Published - 1 Jan 1997
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/j.1600-0609.1997.tb00975.x

Cite this

@article{feea47fe011f4299b8dd711b0f7bfb04,

title = "Lymphoma and systemic sclerosis - An uncommon association or possible coincidence of two disorders with a fatal outcome [2]",

author = "Haviv, \{Y. S.\} and A. Ben-Yehuda and A. Polliack and R. Safadi",

year = "1997",

month = jan,

day = "1",

doi = "10.1111/j.1600-0609.1997.tb00975.x",

language = "English",

volume = "59",

pages = "194--196",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Lymphoma and systemic sclerosis - An uncommon association or possible coincidence of two disorders with a fatal outcome [2]

AU - Haviv, Y. S.

AU - Ben-Yehuda, A.

AU - Polliack, A.

AU - Safadi, R.

PY - 1997/1/1

Y1 - 1997/1/1

UR - https://www.scopus.com/pages/publications/0030759990

U2 - 10.1111/j.1600-0609.1997.tb00975.x

DO - 10.1111/j.1600-0609.1997.tb00975.x

M3 - Letter

C2 - 9310129

AN - SCOPUS:0030759990

SN - 0902-4441

VL - 59

SP - 194

EP - 196

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 3

ER -